Tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a profile of its use Anthony Markham Adis Drug Q&A 21 October 2021 Pages: 557 - 562
Subcutaneous vedolizumab in moderately to severely active ulcerative colitis or Crohn’s disease: a profile of its use Sheridan M. Hoy Adis Drug Q&A 11 November 2021 Pages: 563 - 572
Educate patients with medication overuse headache, and intervene, when necessary Caroline FentonArnold Lee Practical Issues and Updates 10 November 2021 Pages: 573 - 578
What will be the role of molnupiravir in the treatment of COVID-19 infection? Antonio VitielloValentina TroianoRaffaele La Porta Commentary 05 November 2021 Pages: 579 - 580
Intranasal metoclopramide for acute and recurrent diabetic gastroparesis in adults Devada Singh-FrancoWilliam R. WolowichDaisy De La Rosa Review Article 06 October 2021 Pages: 581 - 589
Language proficiency and warfarin-related adverse events in older immigrants and Canadian residents: a population-based cohort study Don Thiwanka WijeratneKaren OkrainecSudeep S. Gill Original Research Article 10 November 2021 Pages: 590 - 598
Prescriber responses to alternative alert builds (AABs) designed for enduring drug shortages: a descriptive study Christine M. Pujol RooksBrian SpoelhofKate Bidwell Horton Original Research Article 09 November 2021 Pages: 599 - 606
Correction to: Intranasal metoclopramide for acute and recurrent diabetic gastroparesis in adults Devada Singh-FrancoWilliam R. WolowichDaisy De La Rosa Correction 22 October 2021 Pages: 607 - 607
